Protocol 101JC402: JCV Antibody Program in Patients with Relapsing Multiple Sclerosis Receiving or Considering Treatment with Tysabri STRATIFY-2

  • Berger, Joseph (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date8/23/102/28/15